CWP
KURA icon

Concord Wealth Partners’s Kura Oncology KURA Stock Holding History

Concord Wealth Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-53
Closed -$1K – 1325
2021
Q3 		$1K Hold
53
– – ﹤0.01% 848
2021
Q2 		$1K Hold
53
– – ﹤0.01% 982
2021
Q1 		$1K Hold
53
– – ﹤0.01% 924
2020
Q4 		$2K Buy
+53
New +$1.86K ﹤0.01% 541

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Concord Wealth Partners's KURA Position: Q4 2021 in Review

Concord Wealth Partners sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 53 shares — an estimated $1K sold.

Concord Wealth Partners first reported a position in KURA in Q4 2020 and held it in 4 quarters. The position peaked at $2K in Q4 2020. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

  • Concord Wealth Partners reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
  • Concord Wealth Partners sold 53 Kura Oncology shares in Q4 2021, an estimated $1K.
  • Concord Wealth Partners first reported a position in Kura Oncology in Q4 2020 and held it in 4 quarters.
  • Concord Wealth Partners's Kura Oncology position peaked at $2K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Concord Wealth Partners's 13F filing for Q4 2021, filed 21 Jan 2022.